PharmAkea
12780 El Camino Real
Suite #200
San Diego
California
92130
United States
Website: http://pharmakea.com/
4 articles about PharmAkea
-
Galecto and PharmAkea Merge to Create Strong Clinical-Stage Company Developing First-in-Class Therapeutics in Fibrosis and Cancer
1/7/2020
Galecto, the leading developer of galectin modulators for the treatment of fibrotic diseases including idiopathic pulmonary fibrosis and cancer, and PharmAkea, Inc., a privately held San Diego-based pharmaceutical company developing novel small molecules against protein targets involved in fibroproliferative disease, announced the two companies will merge.
-
PharmAkea Announces Successful Completion Of A Phase I Trial In Healthy Subjects For Its Novel LOXL2 Inhibitor, PAT-1251
8/22/2017
-
PharmAkea Extends Collaboration With Celgene
11/18/2016
-
PharmAkea, Celgene Corporation and Bay City Capital Collaborate to Advance Innovative Oral Therapies to Benefit Patients With Cancer and Fibrotic Disease
10/4/2013